companydata.dkcompanydata.dk

Jorgensen Biotech Consulting ApS: Financial statements 2026

CVR: 42981761

Source: annual report 2026, Danish Business Authority

01/07/2025 – 30/06/2026

Jorgensen Biotech Consulting ApS (CVR 42981761) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. That is an increase of 36.7% compared with the year before. Equity in the 2026 report amounted to DKK 328,288. The solvency ratio was 30.7%. The company had 1 employee in the financial year.

Gross Profit
DKK 3,669,337
Profit/Loss
DKK 462,628
Equity
DKK 328,288
Total Assets
DKK 1,069,625
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-3.7M463K328K1
2025-2.7M-374K-134K1
2024-2.4M247K361K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Jorgensen Biotech Consulting ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2026

Jorgensen Biotech Consulting ApS changes addressApr 1, 2026

Address changed to Dronningens Vænge 11 st. tv, 2800 Kongens Lyngby (April 1, 2026).

About Jorgensen Biotech Consulting ApS

Jorgensen Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Kjærsgaard Jørgensen. The company is owned by JoBiCo Holding ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. Equity in the 2026 report amounted to DKK 328,288.

Source: annual report 2026, Danish Business Authority

Other financial years